advanced search

Welcome: Guest

log in

Outsourcing Chemistry Services Made Easy

A Guide for the Pharmaceutical and Biotech Industries

Publication Date January 2007
Publisher Biopharm Knowledge
Product Type Report
Pages 120
ISBN Number not applicable
Product Code BKP00008
Buy this product or for assistance call +44 20 7060 7474

Summary

More pharmaceutical and biotech companies are outsourcing more of their work than ever before - it can save time and money. But to succeed you need to understand the processes involved and getting it wrong can be disastrous. This new report provides a clear, comprehensive guide to the processes involved in outsourcing chemical and biotech development and production. It also contains in-depth interviews with development service providers and outsourcers to give a real life understanding of the issues from both sides of the fence. It will help you to:
  • Understand the rationale for outsourcing
  • See how outsourcing fits into the R&D continuum
  • Select process development providers
  • Negotiate contracts
  • Manage the outsourcing process
  • Understand when to outsource - and when not to
  • Minimise outsourcing risk
And it has a full listing of service providers categorised by services offered and location. Contents include:
  • Rational for outsourcing
  • Research and development continuum
  • Selecting a process development provider
  • Contract negotiation
  • Managing outsourcing
  • Risk management
  • Outsourcing economics
  • Interviews with outsourcing companies
  • Interviews with outsourcers
  • Outsourcing directory

Content

  • 1.0 Introduction
    • 1.1 Historical Perspective
    • 1.2 Report Objectives and Structure
      • 1.2.1 Terminology
    • 1.3 Overview of Outsourcing Markets
  • 2.0 Rationale for Outsourcing
    • 2.1 Reducing Cost and Maximising Profit
    • 2.2 Technology
    • 2.3 Capacity
    • 2.4 Equipment
    • 2.5 Facilities and Infrastructure
    • 2.6 Skilled Personnel
    • 2.7 Speed
    • 2.8 Flexibility
    • 2.9 Reducing Risk
  • 3.0 Drug Research and Development Continuum
    • 3.1 Compound Libraries
    • 3.2 Competitor Standards
    • 3.3 Radiolabelled Compounds
    • 3.4 Custom Synthesis Options
    • 3.5 Research Chemicals
    • 3.6 Resynthesis Compounds
    • 3.7 Outsourcing Research Services
      • 3.7.1 Industry Academic Collaboration
      • 3.7.2 Contract Research by FTE
    • 3.8 Process Development Services
  • 4.0 How to Select a Process Development Provider
  • 5.0 Negotiating the Contract
  • 6.0 Managing Outsourcing Contracts
  • 7.0 Rationale Against Outsourcing
    • 7.1 Retention of Core Competencies
    • 7.2 Loss of IP
    • 7.3 Internal Versus External Cost
    • 7.4 Missing Deadlines
    • 7.5 Missing Quality Targets
    • 7.6 Lock-in Contracts
  • 8.0 Minimising Outsourcing Risk
    • 8.1 Ways For Limiting Probability
      • 8.1.1 Structured Contractor Selection
      • 8.1.2 Clearly Defined Deliverables
      • 8.1.3 Setting up a Solid Contract
      • 8.1.4 Monitoring and Diligence
      • 8.1.5 Protection of IPR
    • 8.2 Ways of Limiting Severity
      • 8.2.1 Establishing Clear Strategy
      • 8.2.2 Contingency Planning
      • 8.2.3 Insurance Provisions
  • 9.0 Outsourcing Economics
    • 9.1 Estimating the Volume of Work
    • 9.2 Estimating the Outsourcing Cost
    • 9.3 Getting the Right Number of Quotations
    • 9.4 Critical Comparison of Quotations
    • 9.5 Off Shoring Beyond the Home Base
    • 9.6 How to Pay for Outsourcing Services
      • 9.6.1 Fee For Service (Fixed Cost)
      • 9.6.2 Full Time Equivalent (FTE)
      • 9.6.3 Flexible or Shared Risk Contracts
      • 9.6.4 Best Efforts (Payment per Batch)
      • 9.6.5 Time and Material
      • 9.6.6 Success Fee Agreements
    • 9.7 Role of Consultants in Outsourcing
  • 10.0 Glossary and List of Abbreviations
  • 11.0 References
  • 12.0 Views and Opinions of CROs
    • 12.1 Derek Faries, Business Development Manager, Charnwood Molecular Ltd
    • 12.2 Dr Colin Piper, Business Development Manager, Key Organics Ltd.
    • 12.3 Denise Bowser, Commercial Director, Onyx Scientific
  • 13.0 Views and Opinions of Existing Outsourcers
    • 13.1 Dr John Milton, Senior Director, Chemistry, Solexa, Inc.
    • 13.2 Dr David Ager, Competence Manager for Homogenous Catalysis, DSM Pharma Chemicals
  • 14.0 CROs Categorised by Location and Services Offered
    • 14.1 Table I - United Kingdom
    • 14.2 Table II - USA & Canada
    • 14.3 Table III - Europe
    • 14.4 Table IV - India, China, Russia & Ukraine
  • 15.0 CRO Directory
    • 15.1 United Kingdom
    • 15.2 USA & Canada
    • 15.3 Europe 96
    • 15.4 India, China, Russia & Ukraine

Industry Events

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>